Sanofi upgraded at Morgan Stanley on potential of amlitelimab vs. Dupixent Sanofi upgraded at Morgan Stanley on potential of amlitelimab vs. Dupixent Post Contentsny, regnRead More You might also be interested in reading Tim Scott sets May target for CLARITY Act markup. September 8, 2025 In Mainstream ← Previous post Next post →